期刊文献+
共找到14篇文章
< 1 >
每页显示 20 50 100
遗传性甲状腺髓样癌MEN2A家系的临床诊治分析 被引量:1
1
作者 张刚 郝帅 +5 位作者 江军 袁文强 黄灶明 张军 罗东林 徐琰 《中国医药导报》 CAS 2016年第15期30-34,76,F0003,共7页
目的探讨遗传性甲状腺髓样癌MEN2A家系的临床诊治特点。方法回顾性分析1个遗传性甲状腺髓样癌MEN2A家系的2例患者的临床资料,同时进行家系成员RET基因调查。结果第1例患者因"甲状腺髓样癌术后复发"入第三军医大学大坪医院(以... 目的探讨遗传性甲状腺髓样癌MEN2A家系的临床诊治特点。方法回顾性分析1个遗传性甲状腺髓样癌MEN2A家系的2例患者的临床资料,同时进行家系成员RET基因调查。结果第1例患者因"甲状腺髓样癌术后复发"入第三军医大学大坪医院(以下简称"我院")行右侧甲状腺残叶切除术+双侧颈部Ⅵ区淋巴结清扫术,术后第83天复查降钙素恢复正常。第2例患者在我院首次就诊后行甲状腺全切除术+双侧颈部Ⅵ区淋巴结清扫术,术后第47天复查降钙素恢复正常。2例患者术后均未出现声音嘶哑,甲状腺旁腺素随访2个月内均恢复正常。基因检测该家系为RET原癌基因第10外显子第611位点TGC-TAC杂合错义突变。系谱中发现第2代成员均患病,第3代成员中有50%的成员为携带RET突变基因的未发病者。结论根据临床表现可以确诊MEN2A,结合RET原癌基因突变筛查和进一步系谱调查可以早期诊断出无病RET突变基因携带者;通过家系调查,发现p.Cys611Tyr相关MEN2A家系属于国内首例,该疾病以甲状腺髓样癌和嗜铬细胞瘤发病为特征,不伴有甲状旁腺功能亢进的表现。 展开更多
关键词 遗传性甲状腺髓样癌 men2A RET原癌基因
暂未订购
M918T基因极高危突变的MEN2A型1例
2
作者 陈焕杰 刘新承 +1 位作者 韦树建 郑海涛 《中国现代普通外科进展》 CAS 2018年第5期414-416,共3页
1病例介绍患者男,28岁,主因"查体发现左侧甲状腺结节及左侧增大淋巴结"于2017年5月19日入住青岛大学附属烟台毓璜顶医院甲状腺外科。查体:颈软,气管居中,左侧甲状腺体积增大,可触及肿物大小约3 cm×2 cm,质韧,边界清楚,活动度可... 1病例介绍患者男,28岁,主因"查体发现左侧甲状腺结节及左侧增大淋巴结"于2017年5月19日入住青岛大学附属烟台毓璜顶医院甲状腺外科。查体:颈软,气管居中,左侧甲状腺体积增大,可触及肿物大小约3 cm×2 cm,质韧,边界清楚,活动度可,随吞咽上下活动。右侧甲状腺未及明显肿物。左侧颈部可及多个肿大淋巴结,大者约2 cm×1 cm,质韧,活动可,无压痛。右侧颈部未及明显肿大淋巴结。 展开更多
关键词 M918T基因 men2A型 甲状腺髓样癌 基因突变
暂未订购
在MEN2A综合征中的预防性甲状腺切除
3
作者 任长才 《国外医学(外科学分册)》 2003年第2期114-115,共2页
关键词 men2A综合征 预防性甲状腺切除 治疗
暂未订购
多内分泌腺瘤病研究进展 被引量:6
4
作者 李小英 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2006年第1期5-9,共5页
多内分泌腺瘤病1型(MEN1)发生的重要原因是MEN1基因突变,导致肿瘤细胞11号染色体不同程度的杂合缺失,menin蛋白消失,临床主要表现有甲状旁腺腺瘤、胃肠胰腺内分泌肿瘤和垂体前叶瘤。多内分泌腺瘤病2型(MEN2)主要由原癌基因RET突变所致,... 多内分泌腺瘤病1型(MEN1)发生的重要原因是MEN1基因突变,导致肿瘤细胞11号染色体不同程度的杂合缺失,menin蛋白消失,临床主要表现有甲状旁腺腺瘤、胃肠胰腺内分泌肿瘤和垂体前叶瘤。多内分泌腺瘤病2型(MEN2)主要由原癌基因RET突变所致,又分为MEN2A和MEN2B,临床表现为甲状腺髓样癌、嗜铬细胞瘤、甲状旁腺增生和黏膜神经纤维瘤。RET基因突变类型有一定的规律性,即基因型和表现型之间有非常好的相关性。本文将主要介绍MEN1和MEN2发生机制方面的最新研究进展。 展开更多
关键词 MENl men2 MEN1基因 RET基因 杂合缺失
暂未订购
多发性内分泌腺瘤病15例临床分析 被引量:2
5
作者 张俊荣 武悦 +4 位作者 王祥 张鹏宇 张梦阳 赵琳琳 孙良阁 《河南医学研究》 CAS 2018年第12期2183-2186,共4页
目的通过对多发性内分泌腺瘤病(MEN)患者的临床表现进行总结,提高对该病的认识。方法回顾性分析2011年1月至2017年10月就诊于郑州大学第一附属医院的15例MEN患者的临床资料。结果 15例患者中,MEN1为12例,8例(66.7%)患甲状旁腺腺瘤或增... 目的通过对多发性内分泌腺瘤病(MEN)患者的临床表现进行总结,提高对该病的认识。方法回顾性分析2011年1月至2017年10月就诊于郑州大学第一附属医院的15例MEN患者的临床资料。结果 15例患者中,MEN1为12例,8例(66.7%)患甲状旁腺腺瘤或增生,8例(66.7%)存在垂体肿瘤,3例(25.0%)存在胰腺内分泌肿瘤,7例(58.3%)合并肾上腺腺瘤,1例存在胸腺癌,1例合并牙龈瘤。MEN2为3例,3例(100.0%)均存在肾上腺嗜铬细胞瘤,2例(66.7%)患甲状腺髓样癌,1例(33.3%)合并甲状旁腺腺瘤。治疗上仍以手术治疗为主要手段,必要时辅以内科治疗。结论 MEN在临床罕见,常以单一腺体为首发症状,临床表现多种多样,漏诊率高。对疑诊为此病的患者应完善相关检查,必要时多学科协助诊疗,做到早发现、早治疗。 展开更多
关键词 多发性内分泌腺瘤 MEN1 men2
暂未订购
ret原癌基因与甲状腺癌关系的研究进展 被引量:2
6
作者 周晓明 张国昌 +1 位作者 赵谨 李锋 《农垦医学》 2004年第1期23-26,共4页
关键词 RET原癌基因 甲状腺癌 发病机制 基因突变 men2
暂未订购
Is new American Thyroid Association risk classification for hereditary medullary thyroid carcinoma applicable to Chinese patients? A single-center study 被引量:7
7
作者 Xiwei Zhang Dangui Yan +6 位作者 Junyi Wang Hanfeng Wan Yongxia Zhang Yabing Zhang Yuqin He Wensheng Liu Bin Zhang 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2017年第3期223-230,共8页
Objective: The American Thyroid Association (ATA) proposed a new risk classification for hereditary medullary thyroid carcinoma (MTC) in 2015. This study aimed to assess whether the new guidelines are suitable for the... Objective: The American Thyroid Association (ATA) proposed a new risk classification for hereditary medullary thyroid carcinoma (MTC) in 2015. This study aimed to assess whether the new guidelines are suitable for the Chinese population, and reported our experience on prophylactic thyroidectomy. Methods: A total of 73 patients from 22 families were screened as rearranged during transfection (RET) mutation carriers from 2010 to 2016 in Cancer Hospital, Chinese Academy of Medical Science; the medical history for each patient was collected. Based on the initial treatment, we identified the risk factors for poor prognosis by univariate and multivariate logistic regression. Then, 4 RET mutation carriers were enrolled for prophylactic thyroidectomy, and their pathological data and follow-up outcomes were recorded. Results: In univariate and multivariate logistic regression analyses, age at initial surgery and risk classification were significant risk factors for stage III/IV hereditary MTC at initial diagnosis. The likelihood was increased by 11.6% per year of age at initial surgery [95% confidence interval (95% CI), 1.040-1.198; P=0.002). It was 7.888 times more likely to have III/IV stage disease for ATA highest risk patients, compared to ATA moderate risk individuals (95% CI, 1.607-38.717; P=0.003). Postoperative pathological results showed all 4 multiple endocrine neoplasia type 2A (MEN2A) patients had C-cell hyperplasia (CCH); multifocal malignancies were detected in 3 of them. All 4 patients were cured biochemically, and none developed permanent hypoparathyroidism. Conclusions: In Chinese individuals, hereditary MTC aggressiveness is in line with the new ATA risk classification. Germline RET gene mutation carriers should undergo prophylactic thyroidectomy according to basal serum calcitonin levels. 展开更多
关键词 Medullary thyroid carcinoma (MTC) rearranged during transfection (RET) genotype-phenotype correlation multiple endocrine neoplasia type 2 (men2) prophylactic thyroidectomy
暂未订购
Multiple endocrine neoplasia 2B: Differential increase in enteric nerve subgroups in muscle and mucosa 被引量:1
8
作者 John M Hutson Pam J Farmer +2 位作者 Cristal J Peck Chung W Chow Bridget R Southwell 《World Journal of Gastrointestinal Pathophysiology》 CAS 2017年第3期142-149,共8页
Multiple endocrine neoplasia 2B(MEN2B) is a rare syndrome caused by an activating mutation of the RET gene, leading to enteric gangliomatosis. This child presented with constipation at 1-mo old, was diagnosed with MEN... Multiple endocrine neoplasia 2B(MEN2B) is a rare syndrome caused by an activating mutation of the RET gene, leading to enteric gangliomatosis. This child presented with constipation at 1-mo old, was diagnosed with MEN2 B by rectal biopsy at 4 mo, had thyroidectomy at 9 mo and a colectomy at 4 years. We studied the extent of neuronal and nerve fibre proliferation and which classes of enteric nerves are affected by examining the colon with multiple neuronal antibodies. Resected transverse colon was fixed, frozen, sectioned and processed for fluorescence immunohistochemistry labelling with antibodies against TUJ1, Hu, ChAT, NOS, VIP, SP and CGRP and cKit. Control transverse colon was from the normal margin of Hirschsprung(HSCR) colon(4-year-old) and a child with familial adenomatous polyposis(FAP, 12 year). Myenteric ganglia were increased in size to as wide as the circular muscle. There was a large increase in nerve cells and nerve fibres. ChAT-, NOS-, VIP-and SP-immunoreactive nerve fibres all increased in the myenteric ganglia. NOS-IR nerves preferentially increased in the muscle, while VIP and SP increased in submucosal ganglia and mucosal nerve fibres. The density of ICC was normal. RET overactivation in MEN2B lead to a large increase in intrinsic nerve fibres in the myenteric and submucosal ganglia, with a relative increase in NOS-IR nerve fibres in the circular muscle and VIP and SP in the submucosal ganglia and mucosa. The changes were associated with severe constipation resulting in colectomy at 4 years. 展开更多
关键词 Enteric nervous system RET Neuroganglioma men2B
暂未订购
Novel p.C620L RET Mutation Detected in a Patient with Medullary Thyroid Carcinoma
9
作者 Rebecca L. Margraf Patti M. F. Krautscheid +2 位作者 David C. Pattison Karl V. Voelkerding Rong Mao 《International Journal of Clinical Medicine》 2012年第6期498-501,共4页
A patient with an apparent sporadic medullary thyroid carcinoma was tested for RET germline mutations by Sanger sequencing of RET exons 10, 11, and 13-16. The patient was heterozygous for two known mutations causative... A patient with an apparent sporadic medullary thyroid carcinoma was tested for RET germline mutations by Sanger sequencing of RET exons 10, 11, and 13-16. The patient was heterozygous for two known mutations causative of Multiple Endocrine Neoplasia type 2 disorder, and both mutations were within codon 620 of RET exon 10, c.1859G > T (p.C620F) and c.1860C > G (p.C620W). In order to determine if these adjacent mutations were in cis or in trans, an unlabeled probe method and high-resolution melting analysis were utilized. The mutations were confirmed to occur in cis, representing a novel mutation, c.1859_1860delinsTG (p.C620L). Sanger sequencing of parental samples did not identify any changes at codon 620, so the p.C620L mutation is also de novo. The early age of onset for medullary thyroid carcinoma and the presence of lymph node metastasis in this patient suggests individuals with the p.C620L mutation should be treated and screened (for pheochromocytomas and parathyroid hyperplasia) as Multiple Endocrine Neoplasia type 2 patients with other RET codon 620 mutations (American Thyroid Association risk level B). 展开更多
关键词 RET men2 MTC MEDULLARY THYROID Carcinoma High Resolution Melting Analysis INHERITED THYROID Cancer
暂未订购
多发性内分泌瘤病
10
作者 Rajesh V Thakker 刘喆隆(译) 肖新华(校) 《国际内科双语杂志(中英文)》 2006年第6期7-9,40-42,共6页
多发性内分泌瘤病(MEN)的特点是在同一患者身上出现2种或2种以上的内分泌腺体肿瘤。此病以往被称为“多发性内分泌腺病”或“多腺性综合征”,现在命名为MEN。MEN有2种主要形式,1型(MEN1型,Wermer's综合征)和2型(MEN2型,Sipple... 多发性内分泌瘤病(MEN)的特点是在同一患者身上出现2种或2种以上的内分泌腺体肿瘤。此病以往被称为“多发性内分泌腺病”或“多腺性综合征”,现在命名为MEN。MEN有2种主要形式,1型(MEN1型,Wermer's综合征)和2型(MEN2型,Sipple’s综合征);两型各自有其特异的内分泌腺体肿瘤生成(表1)。MEN综合征的临床表现与肿瘤的部位及其分泌产物有关。对每种肿瘤的诊断和治疗与非MEN患者的相类似。 展开更多
关键词 多发性内分泌瘤病 men2 多发性内分泌腺病 内分泌腺体 肿瘤生成 综合征 临床表现 患者 1型
暂未订购
To Explore the Relationship between Lower Extremity Vascular Sclerosis and Osteoporosis in Elderly Men with Type 2 Diabetes Mellitus
11
作者 Silu Jiang Hao Wang +1 位作者 Fuxia Xie Li Xia 《Advances in Bioscience and Biotechnology》 2023年第11期457-464,共8页
Objective: To investigate the correlation between lower extremity vascular sclerosis and osteoporosis in elderly men with type 2 diabetes mellitus. Methods: A total of 359 elderly male patients with type II diabetes h... Objective: To investigate the correlation between lower extremity vascular sclerosis and osteoporosis in elderly men with type 2 diabetes mellitus. Methods: A total of 359 elderly male patients with type II diabetes hospitalized in the First Affiliated Hospital of Chongqing Medical University from January 2018 to June 2023 were retrospectively collected. According to the BMD (Bone Density Value), the patients were categorized into osteoporotic (T ≤ -2.5, n = 248) and non-osteoporotic groups (T > -2.5, n = 111). T test and Chi-square test were used to evaluate the differences in clinical data, biochemical markers and ABI between two groups. Multivariate logistic regression was used to analyze the risk factors of osteoporosis in elderly men with type 2 diabetes mellitus. Results: Compared with the non-osteoporotic group, the differences in diabetes course, systolic blood pressure, ABI, BMI, uric acid, triglyceride, and HDL in the osteoporotic group were statistically significant (P < 0.05). Logistic multivariate regression analysis showed that lower extremity vascular sclerosis was an independent risk factor for osteoporosis in elderly men with type 2 diabetes mellitus (P Conclusion: Atherosclerosis of the lower extremities in elderly men with T2DM is closely related to osteoporosis, and can lead to a decrease in bone mass, and an increase in osteoporosis. 展开更多
关键词 Elderly Men with Type 2 Diabetes Mellitus Lower Extremity Atherosclerosis OSTEOPOROSIS
暂未订购
行RET原癌基因检测的多发性内分泌肿瘤2B型一例 被引量:3
12
作者 张永侠 张彬 +2 位作者 刘文胜 杨琳 徐震纲 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2014年第5期422-424,共3页
多发性内分泌肿瘤( multiple endocrine neoplasia ,MEN)是指在同一患者身上同时或者先后出现2个或2个以上的内分泌腺体肿瘤而产生的一种以受累腺体功能亢进为表现的临床综合征。 MEN分为两型,即MEN1和MEN2。 MEN2的发病率大约为每... 多发性内分泌肿瘤( multiple endocrine neoplasia ,MEN)是指在同一患者身上同时或者先后出现2个或2个以上的内分泌腺体肿瘤而产生的一种以受累腺体功能亢进为表现的临床综合征。 MEN分为两型,即MEN1和MEN2。 MEN2的发病率大约为每年1.25~7.5例/千万人口。根据受累的腺体、临床表型及家族中受累成员数量的不同, MEN2还可进一步分为三种亚型:MEN2A、MEN2B及家族性甲状腺髓样癌。 展开更多
关键词 多发性内分泌肿瘤 基因检测 家族性甲状腺髓样癌 2B型 RET men2B 内分泌腺体 原癌
原文传递
多发性内分泌肿瘤2b型(附一例报告并文献复习) 被引量:3
13
作者 燕东亮 许纯孝 +3 位作者 张东青 曹庆伟 孟彦 孙晓文 《中华泌尿外科杂志》 CAS CSCD 北大核心 2001年第11期688-690,共3页
目的 提高对 2b型多发性内分泌肿瘤 (MEN2b)的认识 ,探讨其诊治方法。 方法 诊治 1例MEN2b病人。该病人同时患有双侧嗜铬细胞瘤、双侧甲状腺髓样癌、多发性粘膜神经瘤、先天性巨结肠、骨骼系统病变等。行嗜铬细胞瘤切除术及甲状腺全... 目的 提高对 2b型多发性内分泌肿瘤 (MEN2b)的认识 ,探讨其诊治方法。 方法 诊治 1例MEN2b病人。该病人同时患有双侧嗜铬细胞瘤、双侧甲状腺髓样癌、多发性粘膜神经瘤、先天性巨结肠、骨骼系统病变等。行嗜铬细胞瘤切除术及甲状腺全切、颈淋巴清除术。进行家系调查 ,结合文献进行讨论。 结果 术后恢复良好 ,仅口服补充甲状腺激素 ,随访 5个月效果良好。 结论 提高认识、选择适当的检查是诊断MEN2b的关键。家系调查和基因诊断很有必要。宜先行嗜铬细胞瘤切除后再处理其他肿瘤。对各发病腺体的处理方式依具体情况而定。 展开更多
关键词 多内分泌腺瘤 嗜铬细胞瘤 甲状腺肿瘤 men2b
原文传递
甲状腺髓样癌RET基因突变的位点分析与靶向治疗进展 被引量:3
14
作者 曹文娟 张大奇 孙辉 《中华内分泌外科杂志》 CAS 2018年第5期426-429,共4页
甲状腺髓样癌(medullary thyroid carcinoma,MTC)是起源于甲状腺滤泡旁细胞(C细胞)的内分泌性肿瘤,侵袭性强,预后较差。RET基因突变已被认为是大多数MTC发病的分子基础,不同类型的MTC常见的RET突变位点不同,相应的临床表现和... 甲状腺髓样癌(medullary thyroid carcinoma,MTC)是起源于甲状腺滤泡旁细胞(C细胞)的内分泌性肿瘤,侵袭性强,预后较差。RET基因突变已被认为是大多数MTC发病的分子基础,不同类型的MTC常见的RET突变位点不同,相应的临床表现和预后也有很大差异。RET基因检测为个体准确的基因诊断、分子风险评估、个体分析和早期预防管理提供有效的帮助。现如今,针对RET基因突变的MTC靶向治疗应运而生,且部分药物已被批临床应用,给予进展期MTC新的希望。 展开更多
关键词 甲状腺髓样癌 RET基因 多发性内分泌腺瘤病2型 靶向治疗
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部